BIPOLAR DISORDER (MANIC DEPRESSION) PIPELINE ASSESSMENT, 2024
DelveInsight's 'Bipolar Disorder (Manic Depression) Pipeline Insight, 2024' report details 22+ pipeline drugs from 22+ companies, segmented by RoA, MoA, and molecule types, with therapies in various clinical stages, including late-stage candidates like Vanda Pharmaceuticals' Iloperidone.
© Copyright 2024. All Rights Reserved by MedPath